FH and COVID-19: In contrast, individuals who experienced severe COVID-19 symptoms demonstrate a further elevation in circulating FH, FHR1 and FHR2 levels 28 days after their initial diagnosis, on top of the higher levels of these proteins seen in these patients versus a healthy cohort in our baseline analysis.